0QMV.LSE Straumann Holding AG
- Market cap
- GBP 1.98B
- P/E
- 50.2x
- P/B
- -
- ROE
- 16.5%
- Dividend yield
- 0.01%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 0QMV.LSE undervalued?
Graham numberThe Graham number of Straumann Holding AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Straumann Holding AG fundamental analysis
No fundamental analysis for Straumann Holding AG yet.
Straumann Holding AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in too…
Full company profileStraumann Holding AG financial statements
Straumann Holding AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 918M | 1.11B | 1.36B | 1.60B | 1.43B | 2.02B | 2.32B | 2.41B | 2.50B | 2.61B |
| Gross Profit | 719M | 840M | 1.03B | 1.20B | 1.03B | 1.53B | 1.70B | 1.79B | 1.78B | 1.77B |
| Operating Income | 227M | 283M | 351M | 400M | 316M | 537M | 530M | 411M | 601M | 538M |
| EBITDA | 259M | 323M | 404M | 479M | 230M | 591M | 685M | 495M | 726M | 696M |
| Net Income | 230M | 273M | 273M | 306M | 91.3M | 396M | 435M | 246M | 388M | 356M |
| EPS | 1.46 | 1.75 | 1.72 | 1.93 | 0.57 | 2.48 | 2.72 | 1.54 | 2.43 | 2.23 |
| Balance Sheet | ||||||||||
| Total Assets | 1.09B | 1.70B | 1.86B | 2.46B | 2.62B | 3.05B | 3.45B | 3.40B | 3.62B | 3.82B |
| Total Liabilities | 456M | 620M | 660M | 1.09B | 1.41B | 1.55B | 1.60B | 1.56B | 1.58B | 1.65B |
| Shareholders' Equity | 634M | 1.08B | 1.20B | 1.36B | 1.20B | 1.50B | 1.85B | 1.84B | 2.04B | 2.16B |
| Cash & Short-term Investments | 166M | 284M | 281M | 262M | 632M | 881M | 697M | 414M | 383M | 490M |
| Total Debt | 200M | 202M | 202M | 456M | 732M | 707M | 705M | 412M | 414M | 503M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 185M | 217M | 277M | 378M | 377M | 560M | 415M | 504M | 483M | 505M |
| Capital Expenditure | 39.2M | 66.6M | 92.9M | 135M | 70.8M | 105M | 162M | 189M | 168M | 176M |
| Free Cash Flow | 146M | 151M | 184M | 244M | 306M | 455M | 254M | 317M | 316M | 330M |
| Ratios | ||||||||||
| ROE | 36.2% | 25.3% | 22.7% | 22.5% | 7.6% | 26.5% | 23.5% | 13.4% | 19.0% | 16.5% |
| ROA | 21.1% | 16.1% | 14.6% | 12.5% | 3.5% | 13.0% | 12.6% | 7.2% | 10.7% | 9.3% |
| Net Profit Margin | 25.0% | 24.5% | 20.0% | 19.2% | 6.4% | 19.6% | 18.7% | 10.2% | 15.5% | 13.7% |
| Debt to Equity | 0.32x | 0.19x | 0.17x | 0.33x | 0.61x | 0.47x | 0.38x | 0.22x | 0.20x | 0.23x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Straumann Holding AG dividends
- Dividend yield
- 0.01%
- Forward dividend
- -
- Payout ratio
- 42.5%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 151M | 0.95 | 42.5% |
| 2024 | CHF 135M | 0.85 | 34.9% |
| 2023 | CHF 127M | 0.80 | 51.8% |
| 2022 | GBP 107M | 0.67 | 24.7% |
| 2021 | GBP 91.4M | 0.57 | 23.1% |
| 2020 | GBP 91.2M | 0.57 | 99.9% |
| 2019 | GBP 83.1M | 0.52 | 27.1% |
| 2018 | GBP 75.1M | 0.47 | 27.5% |
| 2017 | GBP 65.1M | 0.42 | 23.9% |
| 2016 | CHF 63.2M | 0.40 | 27.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Apr 20, 2022.
Who owns Straumann Holding AG
- Insiders 28.81%
- Institutions 42.63%
- Public & others 28.57%
- Shares outstanding 15.8M
- Free float 113M
Straumann Holding AG company profile
- Company name
- Straumann Holding AG
- Ticker
- 0QMV.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 11,582
- Fiscal year end
- December
- Address
- Peter Merian-Weg 12, Basel, Switzerland, 4002
- Phone
- 41 61 965 11 11
- Website
- straumann.com
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Straumann Holding AG management
10- Mr. Guillaume DaniellotCEO, Interim Head of Dental Service Organizations & Member of Executive Management Board · born 1970
- Ms. Isabelle WegeCFO & Member of Executive Management Board · born 1985
- Mr. Kok-Kien LohRegional Head Asia Pacific & Member of the Executive Management Board · born 1967
- Mr. Holger HadererRegional Head of Europe, Middle East & Africa and Member of Executive Management Board · born 1969
- Mr. Sébastien RocheChief Operations & Supply Chain Officer and Member of Executive Management Board · born 1972
- Mr. Florian KirschHead of Integrated Dental Technologies & Member of Management Board · born 1982
- Mr. Andreas UtzHead of Implantology Business Unit (IBU) and Member of Executive Management Board · born 1976
- Ms. Sara DalmassoHead of the Dental Service Organization (DSO) and Member of Executive Management Board · born 1977
- Mr. Thomas FrieseChief Technology & Information Officer and Member of Executive Management Board · born 1975
- Mr. Alexei CostaExecutive VP of Latin America, President Neodent & Member of Executive Management Board · born 1978